Anti-leprosy drugs inhibit the complement-mediated solubilization of pre-formed immune complexes in vitro.
Incubation of pre-formed immune complexes (IC) (125I-HSA--anti-HSA) with normal human serum resulted in solubilization of IC. When various anti-leprosy drugs were added to human sera, solubilization of IC was fairly explicit with clofazimine, whereas this effect was marginal with dapsone. Rifampicin hardly displayed this effect. Aspirin, chloroquine, and prednisolone, the drugs used in addition to multi-drug therapy to control reactions in leprosy, were in a position to inhibit the solubilization of 125I HSA--anti-HSA by normal serum only at a very high dose. From the current data of the inhibition of solubilization of pre-formed IC along with our earlier observations on the modulation of complement-mediated haemolysis by these drugs, it may be possible to postulate that clofazimine as well as chloroquine affect early complement components. This may in turn be responsible for preventing the deposition of C3 complement onto IC.
Kashyap
A
A
Department of Immunology, Vallabhbhai Patel Chest Institute, University of Delhi, India.
Sehgal
V N
VN
Sahu
A
A
Saha
K
K
D000936:Antigen-Antibody Complex / Q000378:metabolism*; D003176:Complement C3 / Q000378:metabolism; D003165:Complement System Proteins / Q000502:physiology*; D004305:Dose-Response Relationship, Drug; D006461:Hemolysis / Q000187:drug effects; D006801:Humans; D007917:Leprostatic Agents / Q000494:pharmacology*; D008297:Male; D012995:Solubility
D000936:Antigen-Antibody Complex; D003176:Complement C3; D007917:Leprostatic Agents; D003165:Complement System Proteins